Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Psychopharmacology (Berl). 2017 Feb 2;234(6):957–975. doi: 10.1007/s00213-017-4534-8

Fig. 3.

Fig. 3

a Distance (±SEM) traveled in each 5-min interval of the locomotor activity test, by RHA-I rats and haloperidol doses (vehicle, n = 8; 0.1 mg/kg, n = 8; 0.25 mg/kg, n = 7). b Distance (±SEM) traveled in each 5-min interval of the locomotor activity test, by RLA-I rats and haloperidol doses (n = 8/group). c Total distance (±SEM) traveled by RHA-I and RLA-I rats in the 30-min activity session. a, b ***p < 0.001, **p < 0.01, *p < 0.05 both doses vs the vehicle-treated group (V); ##p < 0.01, #p < 0.05 vs the vehicle-treated group (dose indicated). T treatment effect (ANOVA), S × T × I strain × treatment × time interval second-order interaction (ANOVA). c ***p < 0.001, **p < 0.01 vs vehicle-treated group (post hoc LSD test following significant S × T × I effect in ANOVA)